MedTrace Logo

Low Exhaled NO and ICS in Suspected Asthma

NCT02771717 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 165

Last updated 2016-05-13

No results posted yet for this study

Summary

The purpose of this study is to determine whether a low exhaled nitric oxide reading (\<27ppb) is a good predictor of a negative response to inhaled steroid treatment for patients with symptoms suggestive of asthma.

Conditions

Interventions

DRUG

Budesonide (Pulmicort)

Budesonide (Pulmicort) - inhaled low dose inhaled steroid - I puff to be taken twice daily

DRUG

Placebo - dummy inhaler

Placebo - dummy inhaler to be taken 1 puff twice daily.

Sponsors & Collaborators

  • University of Nottingham

    lead OTHER

Principal Investigators

  • Tim Dr Harrison, MD · University of Nottingham

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2017-07-31
Completion
2018-07-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02771717 on ClinicalTrials.gov